AREV Life Sciences Global Corp. (AREVF)
| Market Cap | 317.62K |
| Revenue (ttm) | 5.33K |
| Net Income (ttm) | -177.08K |
| Shares Out | 31.76M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 23,333 |
| Average Volume | 9,159 |
| Open | 0.0100 |
| Previous Close | 0.0100 |
| Day's Range | 0.0100 - 0.0100 |
| 52-Week Range | 0.0050 - 0.1050 |
| Beta | 6.85 |
| RSI | 43.67 |
| Earnings Date | May 2, 2025 |
About AREV Life Sciences Global
AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company’s pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES-TORE, a product based on organic plant nutrition for patients with overt clinical need for rational enhanced caloric intake and micronutrient suppleme... [Read more]
Full Company ProfileFinancial Performance
In 2022, AREV Life Sciences Global's revenue was 49,113, a decrease of -80.74% compared to the previous year's 254,996. Losses were -1.44 million, 45.8% more than in 2021.
Financial numbers in CAD Financial StatementsNews
Kevin Phelps, CPA Appointed Chief Operating Officer of Arev Life Sciences Global Corporation & Warrant Offering
VANCOUVER, BC , April 21, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation announc...
AREV Life Sciences Global Corporation announces engagement of TransBIOTech to facilitate preclinical therapeutic pipeline development
VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) ( “ AREV” or the “ Company ”) announced today its initial ...
AREV Life Sciences Completes Lab and Fungi Fruiting Room Build
VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- via InvestorWire - AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) announces today completion of its f...
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB
REVISED RELEASE first issued July 28, 2021
AREV Announces Brian Cameron as Chief Financial Officer
VANCOUVER, British Columbia, Sept. 02, 2021 (GLOBE NEWSWIRE) -- AREV LIFE SCIENCES GLOBAL CORP. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce Brian Cameron as Chief Financi...
Data Presented at the 11th IAS Conference on HIV Science Supports AREV's Development of SUS-TAINN™, a Ready-to-Use Therapeutic Food to Treat Global Malnutrition and Starvation
VANCOUVER, British Columbia , July 22, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce the Company's RUTF product developmen...
AREV Annual and Special General Meeting Results
Appoints Mel Maxwell as an AREV Director Appoints Mel Maxwell as an AREV Director
AREV Expands Operations to Rochester New York Establishing Wholly Owned U.S. Subsidiary, AREV Life Sciences, Inc.
VANCOUVER, British Columbia, July 06, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce the Company has established a wholly o...
AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins For Use in Its Ready-To-Use Therapeutic Foods
VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) Through its subsidiary AREV Cambodia is pleased to announce t...
AREV CEO Michael Withrow Buys 900,000 Shares of Company Stock
VANCOUVER, British Columbia, June 11, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce that its Chief Executive Officer, Mich...
Germinator and AREV Nanotech Brands Inc. Sign Distribution Agreement to Provide the Genesis Platform of Surface Disinfection to Global Public Health Commodity Procurement Programs
The partnership will help serve a dire need for surface disinfectant treatments to prevent the spread of highly infectious diseases to vulnerable populations in developing nations The partnership will...
AREV Engages Dr. Harold C. Smith to Join Scientific Advisory Board
VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV”) is pleased to announce the appointment of Dr. Harold C. Smith to its Scientifi...
AREV Life Sciences Expands its Extraction Results to Clinical Characterization of Compounds, Development of Advanced-Stage Therapeutic Foods and Discovery of Plant-Based Drugs
VANCOUVER, British Columbia, June 01, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (”AREV” or the “Company”) is pleased to announce it has expanded its extraction results...
AREV Nanotec Board of Directors Welcomes Kevin Phelps
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Nanotec” or “AREV”), is pleased to announce the addition of Kevin J. Phelps to i...
AREV NanoTec joins BIO
VANCOUVER, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Nanotec” or “AREV”), is pleased to announce that the Company has become a member...